Tumorsphere assay provides more accurate prediction of in vivo responses to chemotherapeutics
- 25 October 2013
- journal article
- research article
- Published by Springer Nature in Biotechnology Letters
- Vol. 36 (3) , 481-488
Abstract
Although the sphere culture system has been widely used in stem cell biology, its application for drug screening is limited due to lack of standardized, rapid analytical tools. To optimize sphere cultures for in vitro screening of drugs, we evaluated the properties of primary tumor cells growing as tumorspheres and compared their chemosensitivity to those of cells growing in monolayer. Most cells in tumorsphere cultures were quiescent whereas cells in monolayer culture had a high mitotic index. Moreover, doxorubicin showed better cytotoxicity than paclitaxel in the sphere cultures, but their efficacy was reversed in the monolayer cultures. Importantly, the response of cytotoxic outcomes for suspension cultures matched the in vivo response better than monolayer cultures, providing support for the use of short term suspension cultures of primary cells as a model for drug testing.Keywords
This publication has 23 references indexed in Scilit:
- Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterizationThe FASEB Journal, 2012
- Novel Cell Culture Technique for Primary Ductal Carcinoma In Situ: Role of Notch and Epidermal Growth Factor Receptor Signaling PathwaysJNCI: Journal of the National Cancer Institute, 2007
- Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast CancerJournal of Clinical Oncology, 2006
- Isolation and In vitro Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell PropertiesCancer Research, 2005
- Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancerProceedings of the National Academy of Sciences, 2005
- In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsGenes & Development, 2003
- Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E1193)Journal of Clinical Oncology, 2003
- Molecular effects of paclitaxel: Myths and reality (a critical review)International Journal of Cancer, 1999
- Integrins, Oncogenes, and Anchorage IndependenceJournal of Cell Biology, 1997
- Generation of Neurons and Astrocytes from Isolated Cells of the Adult Mammalian Central Nervous SystemScience, 1992